BackHims & Hers Health Overview
Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Target Price

See Hims & Hers Health's analyst price targets ($31) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.77

Average Target Price

$30.556.2% upside

10 analysts in the last 4 months

High: $40 | Low: $23

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-09UBS$3728.6% upsideOpen
2026-07-01Canaccord Genuity$4039% upsideOpen
2026-06-17Barclays$3935.6% upsideOpen
2026-06-02Leerink PartnersMichael Cherny$2513.1% downsideOpen
2026-05-26UBS$2513.1% downsideOpen
2026-05-22UBS$2320.1% downsideOpen
2026-05-12Jefferies$24.514.8% downsideOpen
2026-05-12UBS$3521.7% upsideOpen
2026-05-12Canaccord Genuity$3211.2% upsideOpen
2026-05-05Deutsche BankGeorge Hill$2513.1% downsideOpen
2026-03-10Deutsche Bank$282.7% downsideOpen
2026-03-09NeedhamRyan MacDonald$304.3% upsideOpen
2026-03-09Oppenheimer$12.556.6% downsideOpen
2026-02-24Barclays$2513.1% downsideOpen
2026-02-24Morgan StanleyCraig Hettenbach$2127% downsideOpen
2026-02-24Evercore ISI$2416.6% downsideOpen
2026-02-24Truist FinancialJailendra Singh$1837.4% downsideOpen
2026-02-24Leerink Partners$17.539.2% downsideOpen
2026-02-10Deutsche BankGeorge Hill$317.8% upsideOpen
2026-02-09Leerink PartnersMichael Cherny$2030.5% downsideOpen
2026-02-02BTIG$60108.6% upsideOpen
2026-01-08Wolfe Research$290.8% upsideOpen
2025-12-08Barclays$4866.8% upsideOpen
2025-12-04Leerink PartnersMichael Cherny$4142.5% upsideOpen
2025-11-12Morgan StanleyCraig Hettenbach$4039% upsideOpen
2025-11-04Seaport Global$59105.1% upsideOpen
2025-11-04Truist FinancialJailendra Singh$3728.6% upsideOpen
2025-11-04UBS$3211.2% upsideOpen
2025-11-04Leerink PartnersMichael Cherny$4659.9% upsideOpen
2025-06-24Truist FinancialJailendra Singh$4556.4% upsideOpen
2025-06-23UBS$304.3% upsideOpen
2025-06-04NeedhamRyan Macdonald$65125.9% upsideOpen
2025-02-19Canaccord GenuityMaria Ripps$68136.4% upsideOpen
2024-12-02Canaccord GenuityMaria Ripps$3832.1% upsideOpen
2024-11-05Piper SandlerKorinne Wolfmeyer$2127% downsideOpen
2024-11-05NeedhamRyan MacDonald$282.7% downsideOpen
2024-10-29Leerink PartnersMichael Cherny$269.6% downsideOpen
2024-10-21Bank of America SecuritiesMichael Cherny$2513.1% downsideOpen
2024-10-14Bank of America SecuritiesMichael Cherny$2320.1% downsideOpen
2024-10-14Truist FinancialJailendra Singh$2320.1% downsideOpen
2024-09-13Bank of America SecuritiesAllen Lutz$2030.5% downsideOpen
2024-08-27CitigroupDaniel Grosslight$2030.5% downsideOpen
2024-08-07JefferiesGlen Santangelo$1837.4% downsideOpen
2024-08-06Deutsche BankGeorge Hill$2320.1% downsideOpen
2024-05-22Canaccord GenuityMaria Ripps$2416.6% downsideOpen
2024-05-07JefferiesGlen Santangelo$1451.3% downsideOpen
2024-05-07Truist FinancialJailendra Singh$1354.8% downsideOpen
2024-05-07Piper SandlerKorinne Wolfmeyer$1354.8% downsideOpen
2024-05-07Deutsche BankGeorge Hill$1644.4% downsideOpen
2024-04-16JefferiesGlen Santangelo$1547.9% downsideOpen

Hims & Hers Health (HIMS) FAQ

Hims & Hers Health (HIMS) currently reports a target price of $31. Use the charts on this page to explore Hims & Hers Health's target price history and peer comparisons.

Analysts' average 12-month price target for Hims & Hers Health is $31, about 6.2% upside from the current share price of $28.77. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $31, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hims & Hers Health, and consider following HIMS for alerts when major investors trade the stock.

Hims & Hers Health is classified in the Consumer Staples sector. On target price, it currently shows $31. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing HIMS with unrelated industries.